Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Osteotech gets $14.5 million damages:

This article was originally published in Clinica

Executive Summary

Osteotech has been awarded damages of $17.5 million in connection with its patent lawsuit against GenSci Regeneration Sciences and its subsidiary GenSci OrthoBiologics. The amount will be reduced by the $3 million that had previously been paid by DePuy AcroMed in settling Osteotech's claims against DePuy in this suit. Last month, the jury determined that two US patents of Osteotech were valid and that GenSci infringed both through its sale of DynaGraft gel and putty products. The court was due to hear arguments on Eatontown, New Jersey-based Osteotech's motion for a permanent injunction and GenSci's motion to stay the injunction pending an appeal.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts